Why we publish our failures
Issue #001: what this letter is, why the autopsies matter more than the wins, and the standing promises we're making to every reader.
A weekly letter on systematic trading — from the team at Ferrante Capital
We build and test trading systems, trade them with our own capital, and write about what actually happens — every Monday, in about five minutes.
You're almost in.
Check your inbox. Confirm, and Monday does the rest.
One email a week. No hot picks, no 'one weird options trick.' Unsubscribe anytime.
{01} The setup {02} The test {03} The verdict — every idea gets all three. Most don't survive.
{01} The river
{02} From the desk
Most trading-strategy marketing shows you an equity curve that goes up and to the right, and hopes you don't ask how it was made. We think the interesting part is exactly the part that gets hidden. So we publish the whole process — the ideas, the tests, the assumptions, and the strategies that die along the way. We trade our own capital using the same systems we write about. We will never sell you picks, and we will never dress a simulation up as a track record.
— the team at Ferrante Capital
Coming — some systems that survive testing may become licensed strategy software. The honest version of that story
Expect one letter every Monday — the setup, the test, and the verdict, in five-ish minutes.
You're almost in.
Check your inbox. Confirm, and Monday does the rest.
{03} Keep reading